Solid lipid and chitosan particulate systems for delivery of siRNA

Pharmazie

Volumn 70, Issue 11, 2015, Pages 698-705

  Senel B ^a   Buyakkoroglu G ^a   Yazan, Y ^b  

^a Anadolu Unäversity ^*  (Turkey)

^b Faculty of Pharmacy   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN NANOPARTICLE; PROTEIN BCL 2; SMALL INTERFERING RNA; SOLID LIPID NANOPARTICLE; CHITOSAN; DRUG CARRIER; LIPID; LIPOFECTAMINE; MESSENGER RNA; NANOPARTICLE;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; ENZYMATIC DEGRADATION; GENETIC TRANSFECTION; HUMAN; LIPOSOMAL GENE DELIVERY SYSTEM; NANOENCAPSULATION; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PH; ZETA POTENTIAL; BLOOD; CHEMISTRY; GENE TRANSFER; IN VITRO STUDY; PROTO ONCOGENE; TUMOR CELL LINE;

CELL LINE, TUMOR; CHITOSAN; DRUG CARRIERS; DRUG COMPOUNDING; GENE TRANSFER TECHNIQUES; GENES, BCL-2; HUMANS; HYDROGEN-ION CONCENTRATION; IN VITRO TECHNIQUES; LIPIDS; NANOPARTICLES; PARTICLE SIZE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84961132060     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2015.5026     Document Type: Article

References (43)

1. Aigner A (2007) Nonviral in vivo delivery of therapeutic small interfering RNAs. Curr Opin Mol Ther 9: 345-352.
2. Alves NM, Mano JF (2008) Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications. Int J Biol Macromol 43: 40-41.
3. Chaturvedi SP, Kumar V (2012) Production techniques of lipid nanoparticles: A review. Res J Pharm Biol Chem Sci 3: 525-541.
4. Chime SA, Onyishi VI (2013) Lipid-based drug delivery systems (LDDS): Recent advances and applications of lipids in drug delivery. Afr J Pharm Pharmaco 7: 3034-3059.
5. Choi C, Kim DG, Jang MJ, Kim TH, JangMK,NahJW(2006)DNAdelivery using lowmolecularwater-soluble chitosan nanocomplex as a biomedical device. J Appl Polym Sci 102: 3545-3551.
6. Dalby B,Cates S, Harris A, Ohki EC, Tilkins ML, Price PJ, Ciccarone VC (2004) Advanced transfection with Lipofectamine 2000 reagent: Primary neurons siRNA and high-throughput applications. Methods 33: 95-103.
7. De Martimprey H, Vauthier C, Malvy C, Couvreur P (2009) Polymer nanocarriers for the delivery of small fragments of nucleic acids: Oligonucleotides and siRNA. Eur J Pharm Biopharm 71: 490-504.
8. Del Pozo-Rodríguez A, Solinís MA, Gascón AR, Pedraz JL (2009) Shortand long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm 71: 181-189.
9. Fernandes JC, Qiu X, Winnik FM, Benderdour M, Zhang X, Dai K, Shi Q (2012) Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: Optimization studies. Int J Nanomedicine 7: 5833-5845.
10. Feng-Fu G, Lin XE, Han QW, Fan YR, Xu YF, Guo D, XuG X, Hou Y (2005) RNA interference remarkably suppresses Bcl-2 gene expression in cancer cells in vitro and in vivo. Cancer Biol Ther 4: 822-829.
11. Gary D, Puri N,Won YY (2007) Polymer-based siRNA delivery: Perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release 121: 64-73.
12. Gencer S, Cebeci A, Irmak-Yazicioglu MB (2010) Silencing of the MMP-3 Gene by siRNA Transfection in Gastric Cancer AGS Cells. J Gastrointestin Liver Dis 20: 19-26.
13. Gvili K, Benny O, Danino D, Machluf M (2006) Poly(DL-lactide-coglycolide acid) Nanoparticles for DNA delivery:waiving preparation complexity and increasing efficiency. Biopolymers 85: 379-391.
14. Hao J, Gu Q, Liu B, Li J, Chen X, Ji Y, Zhu, Z and Lin Y (2007) Inhibition of the proliferation of human gastric cancer cells SGC-7901 in vitro and in vivo using Bcl-2 siRNA. Chinese Med J-Peking 120: 2105-2111.
15. He SN, Li YL, Yan JJ, Zhang W, Du YZ, Yu HY, Hu FQ, Yuan H (2013) Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, andDNAfor gene delivery. Int J Nanomedicine 8: 2859-2869.
16. Heydenreich AV,Westmeier R, Pedersen N, Poulsen HS and Kristensen HG (2003) Preparation and purification of cationic solid lipid nanosphereseffects on particle sizephysical stability and cell toxicity. Int J Pharm 254: 83-87.
17. Howard KA (2009) Delivery of RNA interference therapeutics using polycation-based nanoparticles. Adv Drug Deliv Rev 61: 710-720.
18. Jacobson GB, Gonzalez E, Spitler R, Shinde R, LeakeD, Kaspar RL, Contag HC, Zare RN (2010) Biodegradable nanoparticles with sustained release of functional siRNA in skin. J Pharm Sci 99: 4261-4266.
19. Jiang HL, Xub CX, Kim YK, Arote R, JereD, Lim HT, Chob MH, Cho CS (2009) The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway. Biomaterials 30: 5844-5852.
20. Kim HR, Kim IK, Bae KH, Lee SH, LeeY, Park TG (2008) Cationic solid lipid nanoparticles reconstituted from lowdensity lipoprotein components for delivery of siRNA. Mol Pharm 5: 622-631.
21. Kumar MNVR, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ (2004) Chitosan chemistry and pharmaceutical perspectives. Chem Rev 104: 6017-6084.
22. Li CX, Parker A, Menocal E, Xiang S, Borodyansky L, Fruehauf JH (2006) Delivery of RNA interference. Cell Cycle 5: 2103-2109.
23. Mehnert W, Mäder K (2001) Solid lipid nanoparticles: Production characterization and applications. Adv Drug Deliver Rev 47: 165-196.
24. Montana G, Bondì ML, Carrotta R, Picone P, Craparo EF, San Biagio PL, Giammona G, Di Carlo M (2007) Employment of cationic solid-lipid nanoparticles as RNA carriers. Bioconjug Chem 18: 302-308.
25. Olbrich C, Müller RH (1999) Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures. Int J Pharm 180: 31-39.
26. Olbrich C, Bakowsky U, Lehr CM, MüllerRH, Kneue C (2001) Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. J Control Release 77: 345-355.
27. Oh YK, Park TG (2009) siRNA delivery systems for cancer treatment. Adv Drug Deliver Rev 61: 850-862.
28. Padhye SG, N agarsenker MS (2013) Simvastatin solid lipid nanoparticles for oral delivery: Formulation development and in vivo evaluation. Indian J Pharm Sci 75: 591-598.
29. Park BK, Kim MM (2010) Applications of chitin and its derivatives in biological medicine. Int J Mol Sci 11: 5152-5164.
30. RaoNM(2010) Cationic lipid-mediated nucleic acid delivery: Beyond being cationic. Chem Phys Lipids 163: 245-252.
31. Rejman J, Oberle V, Zuhorn IS, HoekstraD (2004) Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 377: 159-69.
32. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A (2004) Rational siRNA design for RNA interference. Nature Biotech 22: 326-30.
33. Sato T, Ishii T, OkahataY (2001) In vitro gene delivery mediated by chitosan Effect of phserumand molecular mass of chitosan on the transfection efficiency. Biomaterials 22: 2075-2080.
34. Saupe A, Rades R (2006) Solid lipid nanoparticles. In: MOZAFARI MR (ED) Nanocarrier Technologies Frontiers of Nanotherapy, Springer, Netherlands, p. 41-43.
35. Souto EB, Wissing SA, Barbos CM, Müller RH (2004) Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 278: 71-77.
36. Subedi RK, Kang KW, Choi HK (2009) Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci 37: 508-513.
37. Takabatake Y, Isaka Y, Mizui M, Kawachi H, Takahara S and Imai E (2007) Chemically modified siRNAprolongedRNAinterference in renal disease. BBRC 363: 432-437.
38. Uddin SN (2007) Cationic lipids used in non-viral gene delivery systems. BMB Rev 2: 58-67.
39. Venkatesan J, Pangestuti R, Qian ZJ, Ryu B, Kim SK (2010) Biocompatibility and alkaline phosphatase activity of phosphorylated chitooligosaccharides on the osteosarcoma MG63 cell line. Funct Biomater 1: 3-13.
40. Yano J, Hirabayashi K, Nakagawa SI, Yamaguchi T, Nogawa M, Kashimori I, Naito H, Kitagawa H, Ishiyama K, Ohgi T, Irimura T (2004) Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer. Clin Cancer Res 10: 7721-7726.
41. Yuan H, Miao J, Du YZ, You J, Hu FQ, Zeng S (2008) Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm 348: 137-145.
42. Zhang S, Zhao B, Jiang H,Wang B, Ma B (2007) Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 123: 1-10.
43. Zhu L, Xie S, Dong Z, Wang X, Wang Y, ZhouW (2011) Effects of poly(lactic-co-glycolic acid) on preparation and characteristics of plasmid DNA-loaded solid lipid nanoparticles. IET Nanobiotechnol 5: 79-85.